• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病是一种多系统疾病。

Parkinson's disease as a multisystem disorder.

作者信息

Klingelhoefer Lisa, Reichmann H

机构信息

Department of Neurology, Technical University Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

出版信息

J Neural Transm (Vienna). 2017 Jun;124(6):709-713. doi: 10.1007/s00702-017-1692-0. Epub 2017 Feb 2.

DOI:10.1007/s00702-017-1692-0
PMID:28155133
Abstract

This article summarises the noteworthy contribution of Professor Jellinger to the understanding of Parkinson's disease (PD) as a disease affecting multiple body- and neurotransmitter-systems. Phosphorylated alpha-synuclein and the formation of Lewy pathology as neuropathological hallmarks of PD seem to spread from the enteric nervous system and the olfactory bulb in a rostrocranial direction to the CNS. Subsequently, a progressive degeneration of the dopaminergic-nigrostriatal system and widespread extranigral pathology affecting different anatomical structures and neurotransmitters are induced causing the various non-motor and motor symptoms of PD.

摘要

本文总结了杰林格教授在将帕金森病(PD)理解为一种影响多个身体和神经递质系统的疾病方面所做出的显著贡献。磷酸化α-突触核蛋白以及路易病理的形成作为PD的神经病理学标志,似乎从肠神经系统和嗅球沿头侧方向扩散至中枢神经系统。随后,多巴胺能黑质纹状体系统逐渐退化,并引发影响不同解剖结构和神经递质的广泛黑质外病理改变,从而导致PD的各种非运动和运动症状。

相似文献

1
Parkinson's disease as a multisystem disorder.帕金森病是一种多系统疾病。
J Neural Transm (Vienna). 2017 Jun;124(6):709-713. doi: 10.1007/s00702-017-1692-0. Epub 2017 Feb 2.
2
Neuropathobiology of non-motor symptoms in Parkinson disease.帕金森病非运动症状的神经病理生物学
J Neural Transm (Vienna). 2015 Oct;122(10):1429-40. doi: 10.1007/s00702-015-1405-5. Epub 2015 May 15.
3
Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.追踪帕金森病动物模型中的神经外核退化:寻求有效的治疗策略。
J Neurochem. 2011 Aug;118(3):326-38. doi: 10.1111/j.1471-4159.2011.07320.x. Epub 2011 Jun 17.
4
The Gut and Nonmotor Symptoms in Parkinson's Disease.帕金森病中的肠道与非运动症状
Int Rev Neurobiol. 2017;134:787-809. doi: 10.1016/bs.irn.2017.05.027. Epub 2017 Jul 3.
5
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?重组腺相关病毒-α-突触核蛋白和丝状α-突触核蛋白模型如何促进我们对帕金森病的理解?
J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):131-155. doi: 10.1111/jnc.13627. Epub 2016 May 4.
6
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.帕金森病病理从大鼠的胃肠道直接传播到大脑。
Acta Neuropathol. 2014 Dec;128(6):805-20. doi: 10.1007/s00401-014-1343-6. Epub 2014 Oct 9.
7
Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.在帕金森病患者中存在独特的肠内磷酸化α-突触核蛋白聚集和基因表达谱。
Acta Neuropathol Commun. 2017 Jan 5;5(1):1. doi: 10.1186/s40478-016-0408-2.
8
A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.对路易体疾病中α-突触核蛋白病理学当前分期的批判性评估。
Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5.
9
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.AAV1/2 诱导的 A53T-α-突触核蛋白在黑质中的过表达导致具有路易小体样病理学和运动障碍的黑质纹状体系统变性:帕金森病的新小鼠模型。
Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.
10
Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.散发性帕金森病的神经病理学:评估和概念变化。
Mov Disord. 2012 Jan;27(1):8-30. doi: 10.1002/mds.23795. Epub 2011 Nov 11.

引用本文的文献

1
Reduction of Festinating Clinical Gait Parameters to Near Normal After Hip Joint Mobilization: A Parkinson's Disease Case Report.髋关节松动术后慌张步态临床参数降至接近正常:一例帕金森病病例报告
Cureus. 2025 Jul 18;17(7):e88242. doi: 10.7759/cureus.88242. eCollection 2025 Jul.
2
Functional remapping in networks of the Parkinsonian brain: A preclinical neuroimaging perspective with clinical correlates.帕金森病大脑网络中的功能重新映射:具有临床相关性的临床前神经影像学视角。
Transl Neurosci. 2025 Jun 14;16(1):20250374. doi: 10.1515/tnsci-2025-0374. eCollection 2025 Jan 1.
3
Epigallocatechin-3-Gallate, Quercetin, and Kaempferol for Treatment of Parkinson's Disease Through Prevention of Gut Dysbiosis and Attenuation of Multiple Molecular Mechanisms of Pathogenesis.

本文引用的文献

1
The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review.未经药物治疗的帕金森病患者非运动症状的范围和性质:一项最新的系统综述。
NPJ Parkinsons Dis. 2015 Jul 9;1:15013. doi: 10.1038/npjparkd.2015.13. eCollection 2015.
2
Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.普通社区中帕金森病前驱期的筛查:一种基于睡眠的方法。
Sleep Med. 2016 May;21:101-5. doi: 10.1016/j.sleep.2015.12.016. Epub 2016 Mar 10.
3
Nonmotor features of Parkinson's disease subtypes.
表没食子儿茶素-3-没食子酸酯、槲皮素和山奈酚通过预防肠道菌群失调和减轻发病机制的多种分子机制来治疗帕金森病。
Brain Sci. 2025 Jan 31;15(2):144. doi: 10.3390/brainsci15020144.
4
Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction.颠覆帕金森病认知的革命:海因茨·赖希曼博士的开拓性研究与未来研究方向。
J Neural Transm (Vienna). 2024 Dec;131(12):1367-1387. doi: 10.1007/s00702-024-02812-z. Epub 2024 Aug 7.
5
Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease.帕金森病黑质纹状体变性进展速率的相关预测因素。
J Neurol. 2024 Aug;271(8):5213-5222. doi: 10.1007/s00415-024-12477-z. Epub 2024 Jun 5.
6
Linking acetylated α-Tubulin redistribution to α-Synuclein pathology in brain of Parkinson's disease patients.将乙酰化α-微管蛋白重新分布与帕金森病患者大脑中的α-突触核蛋白病理联系起来。
NPJ Parkinsons Dis. 2024 Jan 2;10(1):2. doi: 10.1038/s41531-023-00607-9.
7
Profiling Analysis of Tryptophan Metabolites in the Urine of Patients with Parkinson's Disease Using LC-MS/MS.使用液相色谱-串联质谱法对帕金森病患者尿液中色氨酸代谢物进行谱分析
Pharmaceuticals (Basel). 2023 Oct 20;16(10):1495. doi: 10.3390/ph16101495.
8
FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.MSC 来源外泌体递送 FTO 靶向 siRNA 通过 m6A 依赖的 ATM mRNA 调控协同缓解帕金森病多巴胺能神经元死亡。
J Transl Med. 2023 Sep 22;21(1):652. doi: 10.1186/s12967-023-04461-4.
9
A mini-review of the role of vesicular glutamate transporters in Parkinson's disease.囊泡谷氨酸转运体在帕金森病中作用的小型综述
Front Mol Neurosci. 2023 May 11;16:1118078. doi: 10.3389/fnmol.2023.1118078. eCollection 2023.
10
Pink1-/- Rats Demonstrate Swallowing and Gastrointestinal Dysfunction in a Model of Prodromal Parkinson Disease.Pink1-/- 大鼠在帕金森病前驱期模型中表现出吞咽和胃肠道功能障碍。
Dysphagia. 2023 Oct;38(5):1382-1397. doi: 10.1007/s00455-023-10567-0. Epub 2023 Mar 22.
帕金森病亚型的非运动特征。
Mov Disord. 2016 Aug;31(8):1095-102. doi: 10.1002/mds.26510. Epub 2016 Feb 10.
4
Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.综述:散发性帕金森病:α-突触核蛋白病理学的发展与分布
Neuropathol Appl Neurobiol. 2016 Feb;42(1):33-50. doi: 10.1111/nan.12298.
5
Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.帕金森病发病机制的研究进展——肠脑轴与环境因素。
Nat Rev Neurol. 2015 Nov;11(11):625-36. doi: 10.1038/nrneurol.2015.197. Epub 2015 Oct 27.
6
Non motor subtypes and Parkinson's disease.非运动亚型与帕金森病。
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S41-6. doi: 10.1016/j.parkreldis.2015.09.027. Epub 2015 Sep 11.
7
How close are we to revealing the etiology of Parkinson's disease?我们距离揭示帕金森病的病因还有多远?
Expert Rev Neurother. 2015 Oct;15(10):1105-7. doi: 10.1586/14737175.2015.1079486. Epub 2015 Aug 17.
8
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?在特发性帕金森病的病理生理学中,细胞死亡是原发性的还是继发性的?
Biomolecules. 2015 Jul 16;5(3):1467-79. doi: 10.3390/biom5031467.
9
Neuropathobiology of non-motor symptoms in Parkinson disease.帕金森病非运动症状的神经病理生物学
J Neural Transm (Vienna). 2015 Oct;122(10):1429-40. doi: 10.1007/s00702-015-1405-5. Epub 2015 May 15.
10
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease.能够解释帕金森病进展和不可逆转性的α-突触核蛋白的特征。
Front Neurosci. 2015 Mar 9;9:59. doi: 10.3389/fnins.2015.00059. eCollection 2015.